Scienture Holdings, Inc. (NASDAQ:SCNX – Get Free Report) was the target of a large drop in short interest in February. As of February 27th, there was short interest totaling 1,393,320 shares, a drop of 41.3% from the February 12th total of 2,374,781 shares. Based on an average trading volume of 299,836 shares, the short-interest ratio is currently 4.6 days. Approximately 4.4% of the company’s stock are short sold. Approximately 4.4% of the company’s stock are short sold. Based on an average trading volume of 299,836 shares, the short-interest ratio is currently 4.6 days.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Scienture stock. Virtu Financial LLC purchased a new position in shares of Scienture Holdings, Inc. (NASDAQ:SCNX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned 0.22% of Scienture as of its most recent SEC filing. 5.68% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts recently issued reports on the company. Wall Street Zen raised Scienture to a “hold” rating in a report on Saturday. Maxim Group started coverage on shares of Scienture in a report on Tuesday, February 24th. They set a “buy” rating and a $1.50 price objective on the stock. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a research report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $1.50.
Scienture Stock Performance
NASDAQ SCNX traded down $0.04 during trading hours on Friday, hitting $0.47. The company had a trading volume of 2,459,412 shares, compared to its average volume of 7,806,787. The business has a 50 day moving average of $0.46 and a 200-day moving average of $0.65. Scienture has a 1-year low of $0.37 and a 1-year high of $3.17. The company has a market cap of $18.99 million, a PE ratio of -0.47 and a beta of 3.01.
Scienture Company Profile
Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.
Featured Stories
- Five stocks we like better than Scienture
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Elon Musk’s $1 Quadrillion AI IPO
- Iran isn’t the real war
- 3 times the government seized private wealth (Are we next?)
Receive News & Ratings for Scienture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scienture and related companies with MarketBeat.com's FREE daily email newsletter.
